Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, Indonesia
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This is a prospective, open label, randomised controlled trial to assess the safety and
efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in children and adults
with uncomplicated Plasmodium falciparum malaria infection. Molecular markers for
antimalarial resistance will also be assessed and the presence of molecular markers in the
parasites will be associated with treatment outcomes.
Phase:
Phase 4
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
Universitas Sumatera Utara University of Sumatera Utara